University of Manitoba
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Manitoba sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
University of Manitoba: 8 sponsored US clinical trials, 2 recruiting.
University of Manitoba sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Community-acquired Pneumonia, with 1 trials.
Upper-quartile sponsor footprint
University of Manitoba sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Lemborexant Treatment of Insomnia Linked to Epilepsy
NCT06262594
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT05848713
Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
NCT04372589
Heparin Anticoagulation in Septic Shock
NCT03378466
Validating the "Foods for Health" Portfolio of Functional Food Products
NCT02341924
Canola Oil Multi-Centre Intervention Trial II
NCT02029833
Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols
NCT01131832
Multicenter Intensivist Weekend Scheduling Study
NCT01145443
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the University of Manitoba pipeline
2 recruiting of 8 indexed (25% open); 5 completed (63%).
Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).
Top condition: Community-acquired Pneumonia (1 trial), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Manitoba: open-pipeline peers nationwide
Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
University of Manitoba sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 25% open enrollment (± trial volume)
- Abdul Latif Jameel Poverty Action Lab · 25% recruiting · 4 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
- Advocate Hospital System · 25% recruiting · 4 trials
Related
What to do with this University of Manitoba page
8 registered trials is a research-attention snapshot, not an endorsement of University of Manitoba or any single study.
- 2 of University of Manitoba's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Community-acquired Pneumonia is the condition University of Manitoba studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Community-acquired Pneumonia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Manitoba pipeline card: 8 registered trials from official public datasets.Report a data error.